Author

S. Dinner

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Improving data capture of the patient experience for young adults with cancer: A randomized controlled trial of precision electronic patient-reported outcomes in community-based oncology practices (ECOG-ACRIN EAQ202).

431 Background: Patient-reported outcomes (PROs) characterize patient perspectives on symptoms, functioning, and health-related quality of life (HRQOL). Despite rising cancer incidence among young adults (YAs), PROs are underutilized, particularly in NCI Community Oncology Research Program (NCORP) sites, where...

J. Salsman, Feng-Hai Duan, S. Dinner et al. · JCO Oncology Practice · 0 citations

Clinical trial Sep 2026

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.

BACKGROUND High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6, known as double-hit lymphoma, is a highly aggressive malignancy with poor outcomes after standard chemoimmunotherapy. We aimed to study whether the addition of the BCL2-inhibitor venetoclax to chemoimmunotherapy in patients with doub...

J. Abramson, S. Geyer, Sharmila Giri et al. · The Lancet Haematology · 0 citations